0

Seratrodast

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP112665437
CAS112665-43-7
Structure
MDL NumberMFCD00875701
Molecular Weight354.44
InChI KeyZBVKEHDGYSLCCC-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 25 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size10MG, 50MG
Storage Conditions2-8°C
1

[Thromboxane A2 Antagonist--Discovery of Seratrodast]

S Terao, M Shiraishi, T Matsumoto, Y Ashida

Yakugaku Zasshi. 1999 May;119(5):377-90.

PMID: 10375998

1

Crystal Structure of 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxo-cyclo-hexa-1,4-dien-1-yl)hepta-noate 1,3-dihy-droxy-2-(hy-droxy-meth-yl)propan-2-aminium Monohydrate: A New Solid Form of Seratrodast

Benyong Lou

Acta Crystallogr Sect E Struct Rep Online. 2014 Sep 20;70(Pt 10):228-30.

PMID: 25484659

1

Population Analysis of the Pharmacokinetics and Pharmacodynamics of Seratrodast in Patients With Mild to Moderate Asthma

E Samara, G Cao, C Locke, G R Granneman, R Dean, A Killian

Clin Pharmacol Ther. 1997 Oct;62(4):426-35.

PMID: 9357394

1

Study on the Usefulness of Seratrodast in the Treatment of Chronic Pulmonary Emphysema

Takahiko Horiguchi, Soichi Tachikawa, Rieko Kondo, Mamoru Shiga, Masahiro Hirose, Koji Fukumoto

Arzneimittelforschung. 2002;52(10):764-8.

PMID: 12442639

1

The Effect of Seratrodast on Eosinophil Cationic Protein and Symptoms in Asthmatics

Toshihiko Fukuoka, Shuji Miyake, Takeshi Umino, Naohiko Inase, Naoko Tojo, Yasuyuki Yoshizawa

J Asthma. 2003 May;40(3):257-64.

PMID: 12807169

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode